|
 Azurn International Limited – Float/IPO expected to close 31 July 2006.
Azurn and Azurn America Inc are leading innovators in delivering business applications known as Convergence in the information and communications technology industry. These applications enable people in different locations to communicate effectively and productively via voice, Data and video whether they are separated geographically or because they use different telecommunications networks.
Azurn’s opportunities in the Convergence markets:
- Integrating voice, data and video so that it is delivered concurrently and easily to allow people to work together productively within and between organisations and their clients;
- Converging wireless, the traditional phone network and broadband networks without deploying additional equipment or requiring the provision of anything further by carrier networks;
- Providing complete control to companies and organisations seeking to manage their own information and communications technology services through an in-house application rather than relying on carrier equipment or any new applications;
- Delivering business solutions on any telecommunications device, anywhere and anytime
Click here for more information and to request a Product Disclosure Statement (PDS).
Closing Next Week!
The Vaccinoma Inc initial public offer will close next Monday 17th July 2006. Vaccinoma Inc is a biopharmaceutical company involved in the development of therapeutic cancer vaccines, for melanoma and breast cancers, some of the most devastating cancers facing patients today.
|
Newsletter #665 - 10th July 2006
Home
